Dynamics of SARS-CoV-2 Vaccine-Induced Antibody Immunity
It is slowly becoming clear that the immunity induced by SARS-CoV-2 vaccination is of overall better quality than that induced by COVID-19.
Gertrud Rey
When Viruses Collide with Parasitic Worms
Infection with some parasitic worms may lead to an impaired immune response against pathogenic infections by other parasites, bacteria, and some viruses.
Early Immune Responses to Herpes Simplex Virus Type I Infection
Early interactions of herpes simplex virus type 1 with the immune system involve both Langerhans cells and a newly characterized dendritic cell. Understanding the dynamics of these initial interactions of the virus with cells of the immune system may result in better strategies for HSV-1/-2 vaccines.
Are the SARS-CoV-2 Vaccines Safe for Pregnant and Lactating People?
Accumulating data suggest that SARS-CoV-2 vaccination of pregnant and lactating people is safe and beneficial for both mother and child.
One and Done
On February 27, 2021, the FDA issued an emergency use authorization for a one-dose SARS-CoV-2 vaccine developed by Janssen Pharmaceutica, a Belgium-based division of Johnson & Johnson.
Bacteria Make Antivirals
Viperin is a conserved antiviral protein that catalyzes the synthesis of chain terminator molecules in both vertebrates and prokaryotes.